Siddha management for Kalanjaga padai (Psoriasis) in childre
Phase 2
- Conditions
- Health Condition 1: L99- Other disorders of skin and subcutaneous tissue in diseases classified elsewhere
- Registration Number
- CTRI/2019/07/020198
- Lead Sponsor
- ational Institute of Siddha
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
children with Erythema, Scaling, Thickness, Itching, Positive Auspitz sign, Candle grease sign
Exclusion Criteria
Eczema
Psoriatic arthritis
Fungal infection
Lesions with secondary infection
Systemic involvement
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Efficacy of the trial drug is measured by PASI SCORE and improvement in the clinical condition is assured by reducing the Degrees of involvement of the body region from 5 to 1.Timepoint: 45 days
- Secondary Outcome Measures
Name Time Method Reduction in the remission of the disease and improvement in the quality of life in children.Timepoint: 45 days